A nitric oxide donor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Research Area

FK-409

Item No. 82290

Technical Information
Formal Name
4-ethyl-2E-(hydroxyimino)-5-nitro-3E-hexenamide
CAS Number
138472-01-2
Synonyms
  • NOR-3
Molecular Formula
C8H13N3O4
Formula Weight
Purity
≥98%
A crystalline solid
DMF: >34 mg/mlDMSO: >20 mg/mlEthanol: >36 mg/mlPBS pH 7.2: >2.2 mg/ml
SMILES
CC/C(=C\C(=N\O)/C(=O)N)/C(C)[N+](=O)[O-]
InChi Code
InChI=1S/C8H13N3O4/c1-3-6(5(2)11(14)15)4-7(10-13)8(9)12/h4-5,13H,3H2,1-2H3,(H2,9,12)/b6-4+,10-7+
InChi Key
MZAGXDHQGXUDDX-AGLLBGTNSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    FK-409 is a NO donor. It liberates NO in a time-dependent manner with a half-life of approximately 40 minutes in phosphate buffer (pH 7.4) at 37°C.1 The IC50 for the inhibition of platelet aggregation is 4.9 µM.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Kita, Y., Hirasawa, Y., Maeda, K., et alSpontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur. J. Pharmacol. 257(1-2), 123-130 (1994).

    2. Fukuyama, S., Hirasawa, Y., Kato, Y., et alStructure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives. J. Pharmacol. Exp. Ther. 282(1), 236-242 (1997).